- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05008978
The Effects on Glycemic and Insulinemic Responses by Fruit Consumption (TGIF)
August 19, 2021 updated by: JeyaKumar Henry, Clinical Nutrition Research Centre, Singapore
The Effects on Glycemic and Insulinemic Responses by Fruit Consumption (TGIF Study)
The health benefits of fruits and their importance in a healthy diet have long been known.
Several intervention studies have included the promotion of fruit as part of the healthy diet and epidemiologic evidences have demonstrated that a diet rich in fruits is associated with the reduction in the risk of many chronic diseases, including type 2 diabetes.
Such beneficial health effects of fruits could be attributed to the presence of dietary fiber, micronutrients (vitamins and minerals), antioxidants and phytochemicals found in them.
However, up to our knowledge, no study has investigate the time-course effects on the co-ingestion of fruits with other food product on postprandial glycaemic response (GR) and insulinaemic response (IR).
The time-course effect will be examined in this study in order to determine its optimal effect on GR and IR.
The investigators also aimed to compare the effects of varying micronutrients content in fruits on GR and IR.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Type 2 diabetes is one of the most common non-communicable diseases found in 415 million adults worldwide in 2015 and the number is expected to increase to 642 million in 2040.
This has serious consequences for healthcare expenditure as it has been estimated that the global health expenditure on diabetes is at least USD$673 billion in 2015 and is forecasted to increase to USD$802 billion in 2040.
This creates a major public health burden and effective treatments and prevention strategies are necessary.
The Asian phenotype has been shown to be more susceptible to diabetes compared to the Western phenotype where more than half (56%) of the population with type 2 diabetes lived in the South-East Asia Region or the Western Pacific Region in 2015.Pharmacological methods through the use of drugs and insulin remains as the conventional strategy in the management of type 2 diabetes.
However, in recent years, dietary interventions have been used as a mean to prevent or delay the onset of type 2 diabetes.
Food has now become the new medicine and a healthy diet is widely believed to play an important role in the prevention of the development of type 2 diabetes.The health benefits of fruits and their importance in a healthy diet have long been established.
Several intervention studies have included the promotion of fruit as part of the healthy diet with epidemiological evidences demonstrating that a diet rich in fruits is associated with a reduction in the risk of many chronic diseases, including type 2 diabetes.
Such beneficial health effects of fruits may be attributed to the presence of dietary fibre, micronutrients (vitamins and minerals), antioxidants and phytochemicals found in them.
However, to our knowledge, no study has investigated the time-course effects of co-ingesting fruits with a carbohydrate-based food product on postprandial glycaemic response (GR) and insulinaemic response (IR).
GR and IR is the effect a food product has on blood glucose and insulin levels respectively, after consumption.
Better control of GR and IR were found to be associated with a lower risk of development of type 2 diabetes and other cardiovascular diseases.
Studies have shown that soluble dietary fibre, which are found in fruits, decrease the rise in blood glucose and insulin level.
Addition of fibre as a food ingredient was also found to modulate glucose response by improving insulin sensitivity.
Antioxidants and phytochemicals in fruits have also been hypothesized to improve insulin sensitivity and hence protect against diabetes.
In the second part of the study, the investigators aim to compare the effects of varying micronutrients content in fruits on GR and IR.
Fruits have highly variable contents of fibre, antioxidants, other nutrients, and phytochemicals that may jointly influence the risk of metabolic diseases.
It has been reported that the consumption of higher anthocyanins content had an inverse relationship with the risk of developing type 2 diabetes.
Varying content of resveratrol, chlorogenic acid and naringin have also been reported to have an association with the risk of type 2 diabetes in animal studies.
Due to the heterogeneous composition found in fruits, it may be plausible that different fruits have varying effects on GR and IR.
Therefore, the investigators hypothesized that varying micronutrients content in fruit plays an essential role in the association with diabetes risk due to a difference in GR and IR.
In this proposed study, the investigators will thus determine whether different micronutrients content present in different fruits have an effect on postprandial on GR and IR.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 117599
- Clinical Nutrition Research Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male
- Chinese Ethnicity
- Age between 21-50 years
- Weight of at least 45 kg
- Body mass index between 18.5 - 25 kg/m2 (inclusive)
- Fasting blood glucose < 5.6 mmol/L
- Normal blood pressure ≤140/90 mmHg
Exclusion Criteria:
- People who smoke
- People with any metabolic diseases or cardiovascular diseases (such as heart disease, hypertension, diabetes mellitus, etc.)
- Having any other diseases involving the small intestine or the colon (e.g., irritable bowel syndrome, inflammatory bowel disease, gastric reflux) or having any liver or kidney disorders or any family history of kidney stones
- People with known glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Have any history of severe vasovagal syncope (blackouts or near faints) following blood draws
- People taking any prescribed medication or dietary supplements which may interfere with the study measurements
- People with medical conditions and/or taking medications known to affect glycaemia (glucocorticoids, thyroid hormones, thiazide diuretics)
- Individuals who have any major organ dysfunction (e.g. cardiovascular, respiratory, hepatic, renal, gastrointestinal) that may influence taste, olfaction, appetite, digestion, metabolism, absorption or elimination of test foods, nutraceutical or drug
- Individuals who have any known food allergies to the food components of the study protocol
- People who intentionally restrict food intake
- Individuals who partake in sports at the competitive and/or endurance levels
- People having active Tuberculosis (TB) or currently receiving treatment for TB
- People who have any known chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
- People who are a member of the research team or their immediate family members. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted
- Have known history of anaemia or thalassemia minor
- Enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC
- Participants who are found to be repeatedly difficult to cannulate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test 1
|
25g of available carbohydrates from White bread with 25g of available carbohydrates from Banana consumed simultaneously at time 0 min
|
Experimental: Test 2
|
25g of available carbohydrates from Banana consumed at time -15 min and 25g of available carbohydrates from white bread consumed at time 0 min
|
Experimental: Test 3
|
25g of available carbohydrates from White bread consumed at time 0 min and 25g of available carbohydrates from Banana consumed at time 15 min
|
Experimental: Test 4
|
25g of available carbohydrates from White bread with 25g of available carbohydrates from Papaya consumed simultaneously at time 0 min
|
Experimental: Test 5
|
25g of available carbohydrates from White bread with 25g of available carbohydrates from Apple consumed simultaneously at time 0 min
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in postprandial blood glucose
Time Frame: 180min
|
Baseline venous blood was collected by cannulation into Vacutainers® (Belton Dickinson Diagnostics) containing disodium EDTA.
Analyse using Beckman Coulter analyser.
(time frame 180min)
|
180min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences in postprandial glycaemic response among banana, papaya and apple
Time Frame: 180min
|
Baseline venous blood was collected by cannulation into Vacutainers® (Belton Dickinson Diagnostics) containing disodium EDTA.
Analyse using Beckman Coulter analyser.
(time frame 180min)
|
180min
|
Differences in insulinaemic response among banana, papaya and apple
Time Frame: 180min
|
Baseline venous blood was collected by cannulation into Vacutainers® (Belton Dickinson Diagnostics) containing disodium EDTA.
Analyse using Beckman Coulter analyser.
(time frame 180min)
|
180min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 25, 2019
Primary Completion (Actual)
April 1, 2021
Study Completion (Actual)
April 1, 2021
Study Registration Dates
First Submitted
August 12, 2021
First Submitted That Met QC Criteria
August 12, 2021
First Posted (Actual)
August 17, 2021
Study Record Updates
Last Update Posted (Actual)
August 25, 2021
Last Update Submitted That Met QC Criteria
August 19, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2019/00691
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
-
King's College LondonUniversity of ReadingCompletedHealthy | Healthy AgingUnited Kingdom
Clinical Trials on Test 1
-
Yonsei UniversityCompletedPostprandial Hyperglycemia
-
Thomas RieglerUniversity of ZurichCompletedChronic Obstructive Pulmonary Disease | COPDSwitzerland
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Coloplast A/SCompletedIleostomy - StomaNetherlands
-
Coloplast A/SCompletedIleostomy - StomaDenmark
-
University of FloridaCompletedParkinson Disease (PD)United States
-
Coloplast A/SCompletedIleostomy - Stoma | Colostomy - StomaDenmark
-
Coloplast A/SCompletedIleostomy - StomaDenmark, Netherlands, Norway, United Kingdom
-
Francesc Bas-CutrinaSuspendedGastrointestinal Subepithelial TumorsSpain
-
Johnson & Johnson Vision Care, Inc.Completed